Skip to content
Screener

Sonoma Pharmaceuticals, Inc. SNOA Q2 2026 earnings

Reported August 6, 2026 · Before market open

Revenue$6.4MBeat by $1.4M
EPS$0.02Beat by $0.32
Revenue estimate$5.0M
EPS estimate-$0.30

Next report

Nov 16, 2026 (in 3 months)
Revenue estimate$5.3M
EPS estimate-$0.10

FAQ

When did Sonoma Pharmaceuticals, Inc. report Q2 2026 earnings?
Sonoma Pharmaceuticals, Inc. (SNOA) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Sonoma Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
Sonoma Pharmaceuticals, Inc. reported revenue of $6.4M and eps of $0.02 for Q2 2026.
Did Sonoma Pharmaceuticals, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $5.0M by $1.4M. EPS beat the consensus estimate of $-0.30 by $0.32.
How did Sonoma Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 59.6% from $4.0M a year earlier.
Where can I find Sonoma Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
You can read the 10-Q periodic report (0001683168-26-006024) directly on SEC EDGAR. The filing index links above go to sec.gov.